Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 3/20 | 0.33 |
| ▸ | TP53 | P04637 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.32 |
| ▸ | GAA | P10253 | 3/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.32 |
| ▸ | RECQL | P46063 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.31 |
| ▸ | HPGD | P15428 | 2/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | ERN1 | O75460 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18531360 | 0.85 | — | — | |
| SCHEMBL10294950 | 0.84 | ATM (0.33) | ATMCYP3A4TSHRTP53ALDH1A1 | |
| SCHEMBL28179914 | 0.80 | CYP3A4 (0.36) | CYP3A4TSHRTP53ALDH1A1GAA | |
| SCHEMBL29893241 | 0.80 | TSHR (0.34) | CYP3A4TSHRMAPTPOLB | |
| SCHEMBL663919 | 0.80 | ATM (0.50) | ATMCYP3A4TSHRALDH1A1SMN1; SMN2 | |
| SCHEMBL732190 | 0.79 | NPSR1 (0.33) | ATMCYP3A4TSHRSMN1; SMN2NPSR1 | |
| SCHEMBL7196359 | 0.79 | CYP3A4 (0.42) | CYP3A4TSHRTP53ALDH1A1GAA | |
| SCHEMBL10260787 | 0.77 | ATM (0.37) | ATMTSHRALDH1A1KDM4ELMNA | |
| SCHEMBL14771785 | 0.75 | ATM (0.33) | ATMSMN1; SMN2 | |
| SCHEMBL847892 | 0.75 | SMN1; SMN2 (0.36) | ATMTSHRALDH1A1GAASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 302 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117700707-A | Cationic polycarbonate resin and preparation method and application thereof | 中国电建集团中南勘测设计研究院有限公司 | 2024-03-15 | — | — | CN | claimed |
| CN-114058294-B | Preparation process of degradable gold powder glue | 江苏兴达文具集团有限公司 | 2023-04-14 | — | — | CN | claimed |
| CN-114058294-A | Preparation process of degradable gold powder glue | 江苏兴达文具集团有限公司 | 2022-02-18 | — | — | CN | claimed |
| CN-111420129-B | Preparation method of degradable polycarbonate coating for reducing corrosion rate of medical magnesium-based material | 江南大学 | 2021-11-02 | — | — | CN | claimed |
| CN-111437442-A | Preparation method of degradable electrophoretic coating for magnesium-based medical implant surface | 江南大学 | 2020-07-24 | — | — | CN | claimed |
| CN-111420129-A | Preparation method of degradable polycarbonate coating for reducing corrosion rate of medical magnesium-based material | 江南大学 | 2020-07-17 | — | — | CN | claimed |
| US-12365761-B2 | Biodegradable ultra-pH sensitive polymers | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2025-07-22 | — | — | US | disclosed |
| CN-119968684-A | Gel electrolyte, curable composition, and power storage device | 东亚合成株式会社 | 2025-05-09 | — | — | CN | disclosed |
| EP-4123782-B1 | NON-AQUEOUS ELECTROLYTE FOR LITHIUM SECONDARY BATTERY | LG ENERGY SOLUTION LTD (KR) | 2024-10-09 | — | — | EP | disclosed |
| WO-2024181055-A1 | GEL ELECTROLYTE, CURABLE COMPOSITION AND POWER STORAGE DEVICE | 東亞合成株式会社 | 2024-09-06 | — | — | WO | disclosed |
| US-12024580-B2 | Resin composition suitable for printing and printing methods | Montanuniversität Leoben (AT) | 2024-07-02 | — | — | US | disclosed |
| US-11978856-B2 | Non-aqueous electrolyte solution for lithium secondary battery | LG ENERGY SOLUTION, LTD. (KR) | 2024-05-07 | — | — | US | disclosed |
| WO-2024070885-A1 | GEL-LIKE ELECTROLYTE, CURABLE COMPOSITION AND POWER-STORAGE DEVICE | 東亞合成株式会社 | 2024-04-04 | — | — | WO | disclosed |
| US-20110151566-A1 | BIODEGRADABLE POLYMERS, COMPLEXES THEREOF FOR GENE THERAPEUTICS AND DRUG DELIVERY, AND METHODS RELATED THERETO | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2011-06-23 | — | — | US | disclosed |
| US-20110151566-A1 | BIODEGRADABLE POLYMERS, COMPLEXES THEREOF FOR GENE THERAPEUTICS AND DRUG DELIVERY, AND METHODS RELATED THERETO | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2011-06-23 | — | — | US | disclosed |
| US-20110152167-A1 | BIODEGRADABLE BLOCK POLYMERS FOR DRUG DELIVERY, AND METHODS RELATED THERETO | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2011-06-23 | — | — | US | disclosed |
| US-20110152167-A1 | BIODEGRADABLE BLOCK POLYMERS FOR DRUG DELIVERY, AND METHODS RELATED THERETO | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2011-06-23 | — | — | US | disclosed |
| US-20100305281-A1 | POLYMERS BEARING PENDANT PENTAFLUOROPHENYL ESTER GROUPS, AND METHODS OF SYNTHESIS AND FUNCTIONALIZATION THEREOF | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2010-12-02 | — | — | US | disclosed |
| US-20100305281-A1 | POLYMERS BEARING PENDANT PENTAFLUOROPHENYL ESTER GROUPS, AND METHODS OF SYNTHESIS AND FUNCTIONALIZATION THEREOF | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2010-12-02 | — | — | US | disclosed |
| CN-101591432-A | Polyoxyethylene glycol-aliphatic poly (ester-carbonic ether) of band allyl group side group and preparation method thereof and purposes | CHANGCHUN APPLIED CHEMISTRY (CN) | 2009-12-02 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11978856-B2 | Non-aqueous electrolyte solution for lithium secondary battery | VDAC1, SLC9B2, SLC9A1 | ATM 2101/4885CYP3A4 3056/4885TSHR 2172/4885 |
| US-12365761-B2 | Biodegradable ultra-pH sensitive polymers | CD44, IDUA, USP7 | ATM 1670/4885CYP3A4 3509/4885TSHR 4501/4885 |
| US-20100305281-A1 | POLYMERS BEARING PENDANT PENTAFLUOROPHENYL ESTER GROUPS, AND METHODS OF SYNTHESIS AND FUNCTIONALIZATION THEREOF | PFAS, PAM, PCNA | ATM 3376/4885CYP3A4 2622/4885TSHR 1728/4885 |
| US-20110152167-A1 | BIODEGRADABLE BLOCK POLYMERS FOR DRUG DELIVERY, AND METHODS RELATED THERETO | SAMM50, ADRM1, UFM1 | ATM 444/4885CYP3A4 947/4885TSHR 1975/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.